Literature DB >> 14978112

Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense.

Masamoto Murakami1, Belen Lopez-Garcia, Marissa Braff, Robert A Dorschner, Richard L Gallo.   

Abstract

The production of antimicrobial peptides and proteins is essential for defense against infection. Many of the known human antimicrobial peptides are multifunctional, with stimulatory activities such as chemotaxis while simultaneously acting as natural antibiotics. In humans, eccrine appendages express DCD and CAMP, genes encoding proteins processed into the antimicrobial peptides dermcidin and LL-37. In this study we show that after secretion onto the skin surface, the CAMP gene product is processed by a serine protease-dependent mechanism into multiple novel antimicrobial peptides distinct from the cathelicidin LL-37. These peptides show enhanced antimicrobial action, acquiring the ability to kill skin pathogens such as Staphylococcus aureus and Candida albicans. Furthermore, although LL-37 may influence the host inflammatory response by stimulating IL-8 release from keratinocytes, this activity is lost in subsequently processed peptides. Thus, a single gene product encoding an important defense molecule alters structure and function in the topical environment to shift the balance of activity toward direct inhibition of microbial colonization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978112     DOI: 10.4049/jimmunol.172.5.3070

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  81 in total

1.  Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability.

Authors:  Fitzroy J Byfield; Qi Wen; Katarzyna Leszczynska; Alina Kulakowska; Zbigniew Namiot; Paul A Janmey; Robert Bucki
Journal:  Am J Physiol Cell Physiol       Date:  2010-10-13       Impact factor: 4.249

2.  [Antimicrobial peptides, Vitamin D₃ and more. How rosacea may develop].

Authors:  J Schauber
Journal:  Hautarzt       Date:  2011-11       Impact factor: 0.751

Review 3.  Intestinal mucosal responses to microbial infection.

Authors:  Lars Eckmann; Martin F Kagnoff
Journal:  Springer Semin Immunopathol       Date:  2005-06-01

4.  In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37.

Authors:  Thorgerdur Sigurdardottir; Pia Andersson; Mina Davoudi; Martin Malmsten; Artur Schmidtchen; Mikael Bodelsson
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

5.  The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system.

Authors:  Peter G Barlow; Yuexin Li; Thomas S Wilkinson; Dawn M E Bowdish; Y Elaine Lau; Celine Cosseau; Christopher Haslett; A John Simpson; Robert E W Hancock; Donald J Davidson
Journal:  J Leukoc Biol       Date:  2006-06-22       Impact factor: 4.962

6.  The role of Candida albicans hyphae and Lactobacillus in denture-related stomatitis.

Authors:  Hakan Bilhan; Tonguç Sulun; Gonca Erkose; Hanefi Kurt; Zayre Erturan; Omer Kutay; Tayfun Bilgin
Journal:  Clin Oral Investig       Date:  2008-12-20       Impact factor: 3.573

Review 7.  AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense.

Authors:  Yuping Lai; Richard L Gallo
Journal:  Trends Immunol       Date:  2009-02-13       Impact factor: 16.687

Review 8.  Topical antimicrobials for burn infections - an update.

Authors:  Mert Sevgi; Ani Toklu; Daniela Vecchio; Michael R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-12

Review 9.  Variation, Indispensability, and Masking in the M protein.

Authors:  Partho Ghosh
Journal:  Trends Microbiol       Date:  2017-08-31       Impact factor: 17.079

10.  Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13.

Authors:  Robert Bucki; Dorota B Namiot; Zbigniew Namiot; Paul B Savage; Paul A Janmey
Journal:  J Antimicrob Chemother       Date:  2008-05-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.